Hrvoje Šimić, MD, PhD
Hrvoje obtained his MD degree from the University of Rijeka Faculty of Medicine in 2006. After graduation he started working as a PhD student in Center for proteomics on monoclonal antibody development and characterization. In 2008 he moved to clinic and started neurosurgery residency at Clinical Hospital Centar Rijeka which he finished in 2015. In parallel to neurosurgical training he worked on experimental glioblastoma (GBM) therapy as a part of his doctoral thesis. Currently he is leading small project aimed at testing prototype of anti CMV/ anti GBM vaccine in parallel with the clinic work. He has published 9 scientific papers and 1 book chapter.
